论文信息 - Preclinical Development Preclinical Characterization of OSI-027 , a Potent and Selective Inhibitor of mTORC 1 and mTORC 2 : Distinct from Rapamycin - 字舞流文

Preclinical Development Preclinical Characterization of OSI-027 , a Potent and Selective Inhibitor of mTORC 1 and mTORC 2 : Distinct from Rapamycin

P. Houghton | P. Gokhale | D. Epstein | N. Gibson | L. Arnold | Christine Mantis | A. Crew | R. Wild | J. Pachter | S. Bhagwat | Yan Yao | Jennifer Kahler | A. Cooke | M. Bittner | Jennifer E. Workman | L. Dudkin | Lorina Dudkin